Understanding Medulloblastoma: A Guide for Parents and Caregivers
At a Glance
Medulloblastoma is the most common malignant pediatric brain tumor, starting in the cerebellum. It is categorized into four distinct molecular subgroups (WNT, SHH, Group 3, and Group 4). These subgroups allow doctors to highly personalize treatment using surgery, radiation, and chemotherapy.
The diagnosis of a brain tumor in your child is a life-altering moment. You are likely feeling overwhelmed, scared, and bombarded with medical terminology. This guide is designed to help you understand your child’s diagnosis, the treatment options, and what to expect in the coming months and years.
Medulloblastoma is a fast-growing embryonal tumor—meaning it begins in primitive cells that were meant to develop into mature brain cells—that starts in the cerebellum, the part of the brain responsible for balance and coordination [1]. It is the most common malignant pediatric brain tumor, though it can also affect adults [2].
While this diagnosis is frightening, the medical community has made incredible strides in treating medulloblastoma. Treatment is now highly precise and personalized based on the molecular makeup of the tumor [3].
This guide is broken down into specific topics to help you navigate this journey step by step:
Your Child's Diagnosis: Finding Your Footing
Learn what a medulloblastoma diagnosis means for your child. Understand survival rates, molecular subgroups (WNT, SHH, Group 3, Group 4), and next steps.
Symptoms and Staging: Mapping the Disease
Learn about medulloblastoma symptoms like morning headaches and ataxia. Understand the Chang staging system (M0-M4), drop metastases, and necessary testing.
The Science of Subgroups: Personalizing the Path Forward
Learn about the four medulloblastoma molecular subgroups (WNT, SHH, Group 3, Group 4) and how genetic markers determine if a tumor is standard or high risk.
Surgery and Pathology: The First Major Milestone
Learn what to expect during medulloblastoma surgery, including maximal safe resection, Posterior Fossa Syndrome, and how to read the WHO pathology report.
Standard of Care: Customizing Radiation and Chemotherapy
Learn about standard medulloblastoma treatments, including craniospinal irradiation, chemotherapy, and targeted therapies tailored to age and tumor subgroup.
The Journey of Survivorship: Monitoring and Late Effects
Learn what to expect during medulloblastoma survivorship. Understand late effects, surveillance MRI schedules, endocrine monitoring, and managing scanxiety.
Your child’s care team is your greatest resource. Use the questions provided in each section to guide your conversations and ensure you are an active partner in your child’s care.
Common questions in this guide
What is medulloblastoma?
What are the different subgroups of medulloblastoma?
What are the standard treatments for medulloblastoma?
Who will be involved in my child's medulloblastoma care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Who will be the primary point of contact for our family during this process?
- 2.Can you connect us with a social worker or child life specialist to help our family cope?
- 3.How does this hospital coordinate care between neurosurgery, oncology, and radiation oncology?
- 4.Are there any clinical trials our child might be eligible for based on their initial diagnosis?
- 5.What is the immediate next step in our child's care plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (3)
- 1
Arrested development: the dysfunctional life history of medulloblastoma.
Tao R, Han K, Wu SC, et al.
Genes & development 2025; (39(1-2)):4-17 doi:10.1101/gad.351936.124.
PMID: 39231614 - 2
Molecular Proteomic Characterization of a Pediatric Medulloblastoma Xenograft.
Tsangaris GT, Dimas K, Malamou A, et al.
Cancer genomics & proteomics 2017; (14(4)):267-275 doi:10.21873/cgp.20037.
PMID: 28647700 - 3
Spinal Ependymomas: An Updated WHO Classification and a Narrative Review.
Villanueva-Castro E, Meraz-Soto JM, Hernández-Dehesa IA, et al.
Cureus 2023; (15(11)):e49086 doi:10.7759/cureus.49086.
PMID: 38125233
This guide provides a general overview of medulloblastoma for educational purposes only. Always consult your child's pediatric oncology team for specific medical advice, treatment planning, and clinical trial eligibility.
Get notified when new evidence is published on Medulloblastoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.